With the burgeoning interest in groundbreaking treatments for type 2 diabetes and excess fat reduction, a head-to-head evaluation of Mounjaro and Peggo has become essential. While both therapies function through similar mechanisms – affecting incretin hormones and glucose-dependent insulinotropic